Triphenylmethanol | CAS:76-84-6

We serve Triphenylmethanol CAS:76-84-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Triphenylmethanol

Chemical Name:Triphenylmethanol
CAS.NO:76-84-6
Synonyms:Triphenylmethanol
Hydroxytriphenylmethane
1,1,1-Triphenylmethanol
Molecular Formula:C19H16O
Molecular Weight:260.33000
 
Physical and Chemical Properties:
Density:1.13
Melting point:160-163ºC
Boiling point:360ºC
Flash point:360-380ºC
Index of Refraction:1.621
 
Specification:
Appearance:White to off-white crystalline powder
Assay:≥98.5%
Loss on drying:≤0.5%
Melting point:161-165ºC
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate



Contact us for information like Triphenylmethanol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,1,1-Triphenylmethanol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Hydroxytriphenylmethane Use and application,Hydroxytriphenylmethane technical grade,usp/ep/jp grade.


Related News: How does the virus spread? The virus is thought to spread from person to person through respiratory droplets emitted by coughing or sneezing — but it’s not clear exactly when a person becomes contagious. There’s currently no evidence that the virus is airborne — meaning, for instance, it doesn’t travel across a large room.Homopiperazine manufacturer The Company’s first-of-kind approach involves engineering human iPSCs in a one-time genetic modification event and selecting a single engineered iPSC for maintenance as a clonal master iPSC line.2-Chlorobenzothiazole supplier The risk to the UK population has been raised from very low to low, according to Public Health England, which says the country is “well prepared for new diseases”.3',5'-cyclic AMP vendor The risk to the UK population has been raised from very low to low, according to Public Health England, which says the country is “well prepared for new diseases”.In April 2019, Glenmark had received approval from the Drugs Controller General of India (DCGI) for Remogliflozin Etabonate after successfully completing Phase-3 clinical trials.